Bio Rad Laboratories Stock Return On Equity

BIO Stock

USD 279.73 1.29 0.46%

Bio Rad Laboratories fundamentals help investors to digest information that contributes to Bio Rad's financial success or failures. It also enables traders to predict the movement of Bio Stock. The fundamental analysis module provides a way to measure Bio Rad's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bio Rad stock.

		Last Reported	Projected for Next Year
	Return On Equity	(0.07)	(0.07)

As of the 19th of April 2024, Return On Equity is likely to grow to -0.07.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Bio Rad Laboratories Company Return On Equity Analysis

Bio Rad's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Bio Rad Return On Equity

-0.0694

Most of Bio Rad's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bio Rad Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Bio Return On Equity Driver Correlations

Understanding the fundamental principles of building solid financial models for Bio Rad is extremely important. It helps to project a fair market value of Bio Stock properly, considering its historical fundamentals such as Return On Equity. Since Bio Rad's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Bio Rad's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Bio Rad's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Accounts Payable	Intangible Assets	Common Stock	Long Term Debt	Good Will	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Short Term Investments	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Accumulated Depreciation	Long Term Debt Total	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		1.0	0.14	1.0	0.4	0.98	0.69	0.08	0.58	0.42	-0.37	0.17	-0.15	-0.8	0.67	0.42	0.62	0.99	0.82	0.98	-0.92	0.01	0.96	-0.67	0.4	0.45	0.44	-0.4
Total Stockholder Equity	1.0		0.08	1.0	0.38	0.97	0.65	0.08	0.59	0.39	-0.35	0.12	-0.18	-0.78	0.67	0.38	0.58	0.98	0.82	0.99	-0.92	-0.04	0.97	-0.67	0.41	0.43	0.4	-0.37
Net Debt	0.14	0.08		0.15	0.07	0.3	0.57	-0.13	-0.45	0.38	-0.07	0.96	0.17	-0.64	-0.13	0.75	0.82	0.2	0.14	0.12	-0.13	0.94	-0.06	-0.18	-0.24	0.45	0.8	-0.72
Retained Earnings	1.0	1.0	0.15		0.34	0.97	0.67	0.09	0.53	0.39	-0.31	0.18	-0.21	-0.82	0.62	0.44	0.63	0.99	0.81	0.99	-0.9	0.04	0.96	-0.66	0.41	0.46	0.45	-0.42
Net Receivables	0.4	0.38	0.07	0.34		0.46	0.68	0.02	0.56	0.76	-0.88	0.21	0.62	-0.26	0.81	0.0	0.29	0.31	0.59	0.26	-0.52	-0.08	0.33	-0.34	-0.03	0.27	0.3	0.12
Total Liab	0.98	0.97	0.3	0.97	0.46		0.81	0.09	0.5	0.52	-0.45	0.35	-0.05	-0.87	0.64	0.5	0.74	0.97	0.82	0.95	-0.91	0.16	0.9	-0.65	0.37	0.53	0.55	-0.48
Total Current Assets	0.69	0.65	0.57	0.67	0.68	0.81		0.1	0.35	0.64	-0.73	0.64	0.3	-0.78	0.59	0.59	0.84	0.68	0.74	0.6	-0.78	0.38	0.49	-0.57	0.22	0.62	0.67	-0.56
Short Term Debt	0.08	0.08	-0.13	0.09	0.02	0.09	0.1		0.11	-0.22	-0.07	-0.27	-0.29	0.01	0.1	0.01	0.03	0.08	0.23	0.07	-0.2	-0.32	0.08	0.24	0.63	0.16	-0.18	0.0
Accounts Payable	0.58	0.59	-0.45	0.53	0.56	0.5	0.35	0.11		0.15	-0.51	-0.35	0.07	-0.17	0.77	-0.3	0.04	0.47	0.66	0.49	-0.7	-0.52	0.61	-0.56	0.18	0.08	-0.07	0.29
Intangible Assets	0.42	0.39	0.38	0.39	0.76	0.52	0.64	-0.22	0.15		-0.64	0.52	0.67	-0.44	0.52	0.21	0.47	0.36	0.33	0.32	-0.33	0.31	0.33	-0.1	-0.12	0.29	0.53	-0.1
Common Stock	-0.37	-0.35	-0.07	-0.31	-0.88	-0.45	-0.73	-0.07	-0.51	-0.64		-0.22	-0.65	0.18	-0.74	-0.1	-0.26	-0.3	-0.48	-0.24	0.5	0.13	-0.22	0.29	-0.1	-0.15	-0.11	0.1
Long Term Debt	0.17	0.12	0.96	0.18	0.21	0.35	0.64	-0.27	-0.35	0.52	-0.22		0.3	-0.64	-0.06	0.67	0.82	0.22	0.15	0.13	-0.16	0.94	-0.03	-0.24	-0.28	0.48	0.82	-0.64
Good Will	-0.15	-0.18	0.17	-0.21	0.62	-0.05	0.3	-0.29	0.07	0.67	-0.65	0.3		0.17	0.3	-0.04	0.02	-0.21	-0.1	-0.26	0.11	0.1	-0.27	0.12	-0.38	-0.17	0.05	0.08
Treasury Stock	-0.8	-0.78	-0.64	-0.82	-0.26	-0.87	-0.78	0.01	-0.17	-0.44	0.18	-0.64	0.17		-0.32	-0.68	-0.93	-0.84	-0.71	-0.79	0.76	-0.55	-0.7	0.62	-0.22	-0.74	-0.85	0.63
Property Plant Equipment	0.67	0.67	-0.13	0.62	0.81	0.64	0.59	0.1	0.77	0.52	-0.74	-0.06	0.3	-0.32		0.05	0.25	0.59	0.78	0.58	-0.73	-0.33	0.65	-0.55	0.09	0.08	0.14	0.04
Current Deferred Revenue	0.42	0.38	0.75	0.44	0.0	0.5	0.59	0.01	-0.3	0.21	-0.1	0.67	-0.04	-0.68	0.05		0.72	0.53	0.39	0.47	-0.36	0.58	0.23	-0.37	0.2	0.45	0.59	-0.95
Short Term Investments	0.62	0.58	0.82	0.63	0.29	0.74	0.84	0.03	0.04	0.47	-0.26	0.82	0.02	-0.93	0.25	0.72		0.65	0.6	0.58	-0.64	0.72	0.45	-0.53	0.08	0.71	0.89	-0.69
Net Tangible Assets	0.99	0.98	0.2	0.99	0.31	0.97	0.68	0.08	0.47	0.36	-0.3	0.22	-0.21	-0.84	0.59	0.53	0.65		0.81	0.99	-0.89	0.07	0.94	-0.68	0.43	0.48	0.47	-0.51
Capital Surpluse	0.82	0.82	0.14	0.81	0.59	0.82	0.74	0.23	0.66	0.33	-0.48	0.15	-0.1	-0.71	0.78	0.39	0.6	0.81		0.78	-0.93	-0.05	0.78	-0.77	0.34	0.57	0.5	-0.28
Deferred Long Term Liab	0.98	0.99	0.12	0.99	0.26	0.95	0.6	0.07	0.49	0.32	-0.24	0.13	-0.26	-0.79	0.58	0.47	0.58	0.99	0.78		-0.87	0.0	0.96	-0.65	0.43	0.42	0.41	-0.45
Accumulated Depreciation	-0.92	-0.92	-0.13	-0.9	-0.52	-0.91	-0.78	-0.2	-0.7	-0.33	0.5	-0.16	0.11	0.76	-0.73	-0.36	-0.64	-0.89	-0.93	-0.87		0.04	-0.84	0.78	-0.4	-0.54	-0.44	0.35
Long Term Debt Total	0.01	-0.04	0.94	0.04	-0.08	0.16	0.38	-0.32	-0.52	0.31	0.13	0.94	0.1	-0.55	-0.33	0.58	0.72	0.07	-0.05	0.0	0.04		-0.13	-0.12	-0.36	0.42	0.79	-0.56
Long Term Investments	0.96	0.97	-0.06	0.96	0.33	0.9	0.49	0.08	0.61	0.33	-0.22	-0.03	-0.27	-0.7	0.65	0.23	0.45	0.94	0.78	0.96	-0.84	-0.13		-0.61	0.39	0.37	0.34	-0.19
Short Long Term Debt	-0.67	-0.67	-0.18	-0.66	-0.34	-0.65	-0.57	0.24	-0.56	-0.1	0.29	-0.24	0.12	0.62	-0.55	-0.37	-0.53	-0.68	-0.77	-0.65	0.78	-0.12	-0.61		-0.01	-0.39	-0.45	0.35
Cash And Equivalents	0.4	0.41	-0.24	0.41	-0.03	0.37	0.22	0.63	0.18	-0.12	-0.1	-0.28	-0.38	-0.22	0.09	0.2	0.08	0.43	0.34	0.43	-0.4	-0.36	0.39	-0.01		0.46	-0.1	-0.23
Net Invested Capital	0.45	0.43	0.45	0.46	0.27	0.53	0.62	0.16	0.08	0.29	-0.15	0.48	-0.17	-0.74	0.08	0.45	0.71	0.48	0.57	0.42	-0.54	0.42	0.37	-0.39	0.46		0.76	-0.37
Net Working Capital	0.44	0.4	0.8	0.45	0.3	0.55	0.67	-0.18	-0.07	0.53	-0.11	0.82	0.05	-0.85	0.14	0.59	0.89	0.47	0.5	0.41	-0.44	0.79	0.34	-0.45	-0.1	0.76		-0.47
Capital Stock	-0.4	-0.37	-0.72	-0.42	0.12	-0.48	-0.56	0.0	0.29	-0.1	0.1	-0.64	0.08	0.63	0.04	-0.95	-0.69	-0.51	-0.28	-0.45	0.35	-0.56	-0.19	0.35	-0.23	-0.37	-0.47

Click cells to compare fundamentals

For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.

Competition

Predict Bio Rad

Return On Equity Over Time

Bio Total Stockholder Equity

Total Stockholder Equity

9.18 Billion

At this time, Bio Rad's Total Stockholder Equity is very stable compared to the past year.

Based on the latest financial disclosure, Bio Rad Laboratories has a Return On Equity of -0.0694. This is 99.71% lower than that of the Life Sciences Tools & Services sector and 99.21% lower than that of the Health Care industry. The return on equity for all United States stocks is 77.61% lower than that of the firm.

Bio Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bio Rad's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bio Rad could also be used in its relative valuation, which is a method of valuing Bio Rad by comparing valuation metrics of similar companies.

Bio Rad is currently under evaluation in return on equity category among related companies.

Bio Rad ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Bio Rad's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Bio Rad's managers, analysts, and investors.

Environment Score

Governance Score

Social Score

Bio Fundamentals

	Return On Equity	-0.0694
	Return On Asset	0.0177
	Profit Margin	(0.24) %
	Operating Margin	0.14 %
	Current Valuation	7.81 B
	Shares Outstanding	23.42 M
	Shares Owned By Insiders	15.23 %
	Shares Owned By Institutions	81.69 %
	Number Of Shares Shorted	564.75 K
	Price To Earning	2.90 X
	Price To Book	0.98 X
	Price To Sales	3.28 X
	Revenue	2.67 B
	Gross Profit	1.57 B
	EBITDA	576.2 M
	Net Income	(637.32 M)
	Cash And Equivalents	434.21 M
	Cash Per Share	62.03 X
	Total Debt	1.41 B
	Debt To Equity	0.16 %
	Current Ratio	5.50 X
	Book Value Per Share	306.51 X
	Cash Flow From Operations	374.94 M
	Short Ratio	3.22 X
	Earnings Per Share	(21.81) X
	Price To Earnings To Growth	1.19 X
	Target Price	409.8
	Number Of Employees	8.03 K
	Beta	0.88
	Market Capitalization	8.25 B
	Total Asset	12.3 B
	Retained Earnings	9.26 B
	Working Capital	2.53 B
	Current Asset	466.61 M
	Current Liabilities	208.93 M
	Net Asset	12.3 B

About Bio Rad Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Bio Rad Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bio Rad using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bio Rad Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Pair Trading with Bio Rad

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bio Rad position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Rad will appreciate offsetting losses from the drop in the long position's value.

Moving against Bio Stock

0.55	VALN	Valneva SE ADR Financial Report 2nd of May 2024	Pair Corr
0.46	DOMH	Dominari Holdings	Pair Corr

The ability to find closely correlated positions to Bio Rad could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bio Rad when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bio Rad - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bio Rad Laboratories to buy it.

The correlation of Bio Rad is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bio Rad moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bio Rad Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Bio Rad can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Bio Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Rad's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:

How To Invest In Bio

Details

Is Bio Stock a good investment?

Details

What is Bio Rad's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Bio Rad Piotroski F Score and Bio Rad Altman Z Score analysis.

You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Complementary Tools for Bio Stock analysis

When running Bio Rad's price analysis, check to measure Bio Rad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Rad is operating at the current time. Most of Bio Rad's value examination focuses on studying past and present price action to predict the probability of Bio Rad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Rad's price. Additionally, you may evaluate how the addition of Bio Rad to your portfolios can decrease your overall portfolio volatility.

	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Equity Valuation Check real value of public entities based on technical and fundamental data
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Economic Indicators Top statistical indicators that provide insights into how an economy is performing
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences

Is Bio Rad's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.56)

Earnings Share

(21.81)

Revenue Per Share

91.453

Quarterly Revenue Growth

(0.07)

Return On Assets

0.0177

The market value of Bio Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Bio Rad Laboratories Stock Return On Equity

Bio Rad Laboratories Company Return On Equity Analysis

Return On Equity

Net Income

Total Equity

Current Bio Rad Return On Equity

Bio Return On Equity Driver Correlations

Bio Total Stockholder Equity

Total Stockholder Equity

9.18 Billion

Bio Return On Equity Peer Comparison

Bio Rad ESG Sustainability

Bio Fundamentals

About Bio Rad Fundamental Analysis

Pair Trading with Bio Rad

Moving against Bio Stock

Complementary Tools for Bio Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY